Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Atlas Venture
Biotech
Judo throws down $100M to knock out kidney disease
Taking the mat is Judo Bio, a biotech armed with $100 million to develop oligonucleotide medicines targeting the kidney.
Gabrielle Masson
Oct 7, 2024 10:42am
Kailera launches with $400M series A, 4 Chinese obesity drugs
Oct 1, 2024 8:30am
Diagonal launches with $128M to grow agonist antibody platform
Apr 3, 2024 6:00am
Triveni raises $92M for I&I pipeline after Modify, Amagma merger
Oct 26, 2023 11:27am
Korro Bio merges with off-pitch Frequency, tacks on $117M
Jul 14, 2023 9:50am
Atlas lands $450M fund to build fresh batch of biotechs
Mar 3, 2022 9:10am
